Synthetic Biology Expert's Insight

Effective regulation of emerging highly personalized cell and gene therapies is crucial in ensuring the safety and efficacy of these groundbreaking treatments. FDA regulatory frameworks are designed to prioritize patient’s

Learn about new strategies that may help address the current limitations of engineered T cells in treating solid tumors.

Learn about the benefits of recently developed CRISPR/Cas tools for engineering T cell therapeutics, including precise modifications, ready-to-use T cell medicines, and improved T cell performance.

Get expert insight on critical advantages of precise mutations enabled by “Presicion Mutant Libraries” for protein engineering.